Skip to content

Clinical trials

Phase 1 Uterine Cervical Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Phase: Phase 1 Clear all

265 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20015
20022
20035
20045
20058
20067
20076
20085
20095
20108
20116
20125
20134
20143
20159
20164
20179
201817
201921
202016
202117
202224
202319
202418
202517
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed121
Recruiting38
Unknown status35
Terminated34
Active, not recruiting21
Withdrawn10
Not yet recruiting3
Suspended2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)17
M.D. Anderson Cancer Center8
Chongqing Precision Biotech Co., Ltd5
Gynecologic Oncology Group5
Eli Lilly and Company4
Masonic Cancer Center, University of Minnesota4
UNC Lineberger Comprehensive Cancer Center4
Anhui Provincial Hospital3
AstraZeneca3
Huazhong University of Science and Technology3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms265
Ovarian Neoplasms80
Endometrial Neoplasms70
Carcinoma, Non-Small-Cell Lung69
Breast Neoplasms52
Squamous Cell Carcinoma of Head and Neck52
Stomach Neoplasms52
Carcinoma, Renal Cell48
Melanoma46
Esophageal Neoplasms42

Trials

Showing 76 to 100 of 265. Each trial links to its page on Pharma Observatory.

165 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.